%0 Journal Article %T ¦Á-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study %A Akira Takashima %A Atsushi Tanaka %A Hiroki Ikenaga %A Kazuoki Dai %A Koichi Node %A Koichi Oshiro %A Kozue Ogasawara %A Masaharu Ishihara %A Masataka Sata %A Michio Shimabukuro %A Osamu Arasaki %A Shinji Kishimoto %A Toshiyuki Niki %A Yohei Inoue %A Yoshisato Shibata %A Yutaka Mori %A on behalf of the Collaborators on the Effect of Miglitol on Glucose Metabolism in Acute Coronary Syndrome (MACS) Study %J Archive of "Cardiovascular Diabetology". %D 2017 %R 10.1186/s12933-017-0571-1 %X The online version of this article (doi:10.1186/s12933-017-0571-1) contains supplementary material, which is available to authorized users %K Acute coronary syndrome %K Glucose fluctuation %K Heart rate variability %K Hypoglycemia %K Miglitol %K Sympathetic nervous system activity %K Type 2 diabetes %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501494/